To clarify how MS pathophysiology, which promotes a positive association of EL with BMI, IL-6, and CRP (Table S8), promotes the negative association between EL and HDL3-apoA-II in humans needs further investigation. This evidence concerns the gene IL6 and myeloid sarcoma.